Continued growth, after a bump: For 2019 we expect the European Health IT market to grow compared to the preceding years. The transactions in the segment show that the trend is moving towards consolidations of Health IT providers and that telemedicine is gaining significant relevance in Europe. In public markets, Health IT still constitutes a comparatively small yet thriving sector.
SEGMENTS COVERED:
Health IT, including: Telemedicine, Big Data, Intelligent Implants, PACS, EHR/HIS and more
REGION COVERED:
Europe
TRANSACTIONS ANALYZED:
closed M&A deals
UK most active country: 231 deals in 2018
Followed by Germany with
Despite the upcoming Brexit in March 2018, the number of acquisitions in the UK remained stable
Majority of buyers are domestic
This year’s M&A report includes in depth country insights for Italy, Denmark, Germany, Austria and Switzerland
Overall Life Sciences transaction Multiples remain on an above average level, only provider valuation has been outperformed by the market benchmark
Pharma is known for its high value deals, e.g. in 2018 the sale of Novartis consumer business to glaxoSmith Kline for more than 10bn
As patient become more conscious of their healthcare coverage, providers have to transform their business structure, which is visible in the high number of deals
In the Medtech segment Imaging and Conventional Medtech show growth, to read about the activity in the Medtech subsegment and about specific deals…download the report
